AstraZeneca reportedly eyeing deal for Korean biosim maker Celltrion

Carly Helfand

confirmed Wednesday that its largest shareholder is in discussions with financial adviser JPMorgan but stressed in a statement that "no definite structure, decision or buyer regarding the stake sale has been determined."

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS